Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Neuraxis Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
NRXS
American
3845
http://neuraxis.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Neuraxis Inc
NeurAxis Announces New Medical Policy Coverage in North Dakota
- Apr 23rd, 2024 1:00 pm
NeurAxis, Inc. (NASDAQ:NRXS) Q4 2023 Earnings Call Transcript
- Apr 12th, 2024 12:44 pm
NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
- Apr 9th, 2024 8:05 pm
NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024
- Apr 1st, 2024 8:15 pm
NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry
- Mar 27th, 2024 1:00 pm
NeurAxis Announces Highmark BCBS Policy Coverage
- Mar 11th, 2024 1:00 pm
NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage
- Mar 4th, 2024 2:00 pm
NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
- Feb 27th, 2024 4:00 pm
NeurAxis Appoints Timothy Henrichs as Chief Financial Officer
- Jan 31st, 2024 2:00 pm
NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer
- Dec 20th, 2023 2:00 pm
NeurAxis Reports Third Quarter 2023 Financial Results
- Nov 20th, 2023 10:30 pm
NeurAxis Announces CareFirst BCBS Policy Coverage
- Nov 15th, 2023 2:00 pm
NeurAxis Secures $3 Million Financing
- Nov 14th, 2023 2:00 pm
NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device
- Nov 8th, 2023 2:00 pm
NeurAxis Announces Results of Comparative Study of IB-Stimâ„¢ and Standard Medical Therapy in Adolescents with Functional Abdominal Pain Disorders
- Sep 26th, 2023 1:00 pm
NeurAxis Reports Second Quarter 2023 Financial Results
- Sep 21st, 2023 12:00 pm
NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase
- Sep 13th, 2023 1:00 pm
EXCLUSIVE: NeurAxis' Nerve Field Stimulation Tech Shows Improved Quality of Life of Adolescents Patients With Irritable Bowel Syndrome
- Sep 12th, 2023 2:15 pm
NeurAxis Announces Publication of Prospective Study Showing IB-Stimâ„¢ Improves Quality of Life of Adolescents with IBS
- Sep 12th, 2023 1:00 pm
NeurAxis Highlights Pediatric Post-Concussion Clinical Study
- Aug 29th, 2023 1:00 pm
Scroll